Thomas Dann, Chief Investment Officer, Cellphire, Inc., based in Rockville, MD

Cellphire is developing technology and products that have potential applications in diverse health care fields from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine.

The fragility of the national supply of platelets is a topic of discussion of several task forces and agencies planning the nation's response to a pandemic such as avian influenza. This and other natural or man-made disasters would interrupt the constant supply of platelets that is needed to maintain an adequate supply or treat bleeding casualties.

Meet Tom Dann and Cellphire by logging in to Cavendish IQ.

Oded Biran, Chief Executive Officer, NeuroDex, based in Boston, Mass.

NeuroDex is bringing the personalized medicine revolution to dementia, neurology, and psychiatry.

On October 15th, Oded Biran delivered an overview of NeuroDex and how his company is leveraging blood-based brain vesicles for advancing the treatment of brain-based, and other neurological indications.

Meet Oded and learn more about NeuroDex by logging in to Cavendish IQ.

Glenn Snow, co-founder and Chief Executive Officer, LactaLogics, Inc., based in Port Saint Lucie, FL

LactaLogics is utilizing state-of-the-art technology so more at-risk infants will be able to have access to safe, high-quality human milk.

Meet Glenn and learn more about LactaLogics by logging in to Cavendish IQ.